Official Title
Hepatic Manifestations and Effect of Long COVID-19 on Patients With Chronic Liver Disease
Brief Summary

To measure the frequency of persistent liver dysfunction (raised liver enzymes, serumalbumin, prothrombin time, etc) in recovered COVID -19 patients.To compare the hepatic manifestations in post COVID -19 patients with and without liverdisease

Detailed Description

The digestive tract, particularly the liver, has recently been reported to be affected by
SARS-CoV-2. Although abnormal liver enzymes were regularly described as an
extra-pulmonary clinical feature, and almost one half of patients experienced grades of
hepatic injury. liver damage in patients with SARS infections was primarily manifested in
the mild and moderate elevation of alanine and/or aspartate aminotransferases (ALT and
AST) with some degree of hypoalbuminemia and hyperbilirubinemia during the early stage of
the illness.

Unknown status
COVID-19

Diagnostic Test: liver function , prothrombin time , INR , US .

analytic

Eligibility Criteria

Inclusion Criteria:

- Patients previously diagnosed by COVID 19 eg : PCR and / or HRCT chest, lab of more
than 1 month duration.

Exclusion Criteria:

- Patients less than 18 y.

- Patients with acute COVID 19.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 90 Years
Countries
Egypt
Locations

Faculty of Medicine
Assiut, Egypt

Khaled Abu Bakr, Study Director
Assiut University

Assiut University
NCT Number
MeSH Terms
COVID-19
Post-Acute COVID-19 Syndrome
Liver Diseases
Thrombin